Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Our aim was to evaluate the efficacy and safety of cisplatin with pemtrexed or vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT). Patients with unresectable stage III non-small-cell lung cancer (NSCLC) were randomly assigned to two regimens. The experimental...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Zhao, Qian, Wang, Zhongtang, Huang, Wei, Wang, Qiang, Yu, Shuzeng, Zhou, Tao, Han, Dan, Wu, Zhenying, Gong, Heyi, Sun, Hongfu, Zhang, Jian, Wei, Yumei, Li, Hongsheng, Zhang, Zicheng, Lin, Haiqun, Li, Baosheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://ncbi.nlm.nih.gov/pubmed/26761213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6871
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky